Post-rejection Prospera trends predict 1-yr outcomes

Post-rejection Prospera trends predict 1-yr outcomes Read the publication

Organ Health

Big advances in kidney care come at a molecular level

Natera^™ uses revolutionary technology to enhance the patient and physician’s ability to assess otherwise undetected rejection events that might lead to loss of the transplanted organ.

Our Tests

Prospera - Tracking the health of your transplanted organ

Natera has optimized our cfDNA technology for early, clinically meaningful rejection assessment.
Kidney
Heart
Lung

Learn more

Renasight - Personalize your kidney disease management

Comprehensive and affordable genetic test for kidney disease to inform and tailor management strategies.
Learn More